Ritlecitinib lower dose Clinical Trials
2 recruitingDrug
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Severe Alopecia Areata
Pfizer140 enrolled41 locationsNCT07029828
Recruiting
Phase 3
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Severe Alopecia Areata
Pfizer225 enrolled80 locationsNCT07029711